Market Size (2025)
$80.28M
Vertical: CNMBase Year: 2025
Market Size (2025)
$80.28M
Projected (2032)
$126.38M
CAGR (2022–2032)
6.7%
Key Players
11+
Market Overview
The global strobilurin intermediates market was valued at USD 80.28 Million in 2025 and is projected to reach USD 126.38 Million by 2032, expanding at a CAGR of 6.68% during 2026–2032. The market has grown steadily from USD 65.85 Million in 2022, and the forecast period adds an absolute value of USD 46.09 Million between 2025 and 2032.
Strobilurin intermediates are the key chemical building blocks used to synthesise strobilurin (quinone outside inhibitor, QoI) fungicides, a class that includes azoxystrobin, pyraclostrobin, trifloxystrobin, kresoxim-methyl, picoxystrobin and fluoxastrobin. Strobilurins act by blocking mitochondrial respiration at the Qo site of the cytochrome bc1 complex and are classified by the Fungicide Resistance Action Committee (FRAC) as Group 11. Since the expiry of the core patents on azoxystrobin and pyraclostrobin, technical-grade production has shifted towards generic manufacturers in China and India, many of which have integrated backwards into the intermediates that determine cost and quality. Demand for these intermediates therefore follows the volume of strobilurin technical produced worldwide, which in turn tracks fungicide use on soybean, cereals, corn, rice, fruits and vegetables.
Key Findings
Largest downstream product segment: Azoxystrobin, with USD 40.14 Million and a 50.0% share in 2025.
Fastest-growing downstream product segment: Pyraclostrobin, at a CAGR of 8.22% over 2026–2032, rising from USD 20.07 Million in 2025 to USD 35.09 Million in 2032.
Largest and fastest-growing purity segment: 98% & Above, with USD 68.24 Million (85.0% share) in 2025 and a CAGR of 6.97%.
Leading region: Asia Pacific, with USD 62.62 Million and a 78.0% share of global value in 2025.
Fastest-growing region: Middle East & Africa, at a CAGR of 7.47% over 2026–2032.
Leading country: China, with USD 38.83 Million in 2025, equal to 48.4% of the global market.
Fastest-growing country: Saudi Arabia, at a CAGR of 8.17% over 2026–2032, followed closely by the UAE at 8.15%.
Segmentation Summary
By downstream product, the market is segmented into azoxystrobin, pyraclostrobin and others. Azoxystrobin intermediates account for half of global value in 2025 (USD 40.14 Million), reflecting azoxystrobin's position as the highest-volume strobilurin active ingredient and its very broad crop label. Pyraclostrobin intermediates (USD 20.07 Million) grow fastest at 8.22%, supported by pyraclostrobin's use in soybean and corn programmes in the Americas and its expanding generic manufacturing base in China and India. The others segment, which covers intermediates for trifloxystrobin, kresoxim-methyl, picoxystrobin and other strobilurins, is valued at USD 20.07 Million in 2025 and grows at 6.35%.
By purity, intermediates of 98% & Above dominate with a 85.0% share in 2025 and a CAGR of 6.97%, as technical manufacturers require high-purity inputs to meet registration specifications and impurity limits. The Below 98% segment (USD 12.04 Million in 2025) grows more slowly at 4.96%.
Competitive Landscape Summary
The market is concentrated by geography but fragmented by company. China hosts the bulk of global capacity for both strobilurin technicals and their key intermediates, with a second, faster-growing manufacturing base in India. The originator companies, Syngenta (azoxystrobin), BASF (pyraclostrobin) and Bayer (the principal marketer of trifloxystrobin), retain leadership in brands, mixture products and registrations, while volume leadership in intermediates and technicals has moved to cost-focused generic producers such as CAC Nantong Chemical, Nutrichem, Limin Group, Jiangsu Yangnong Chemical, Hailir and Shandong Kangqiao. Indian producers including Heranba Industries and Best Agrolife are adding strobilurin technical capability under domestic manufacturing registrations. Competition is driven by process cost, backward integration into intermediates such as benzofuranone, 2-cyanophenol and 4,6-dichloropyrimidine, environmental compliance and access to registrations in key markets.
Challenges and Opportunities
The principal challenges are recurring price pressure from Chinese overcapacity, the 2023–2024 global crop-protection destocking cycle, the spread of QoI resistance (notably the G143A mutation) that limits stand-alone use, and tightening environmental and safety regulation of chemical plants. Opportunities arise from rising fungicide intensity in Brazil and other Latin American soybean markets, growing combination products that pair strobilurins with SDHI and triazole fungicides, China-plus-one sourcing that favours Indian intermediates producers, and process innovations that lower solvent use, waste and cost per kilogram.
Future Outlook
The market is expected to grow every year of the forecast period, from USD 85.73 Million in 2026 to USD 126.38 Million in 2032. Asia Pacific will remain the production and consumption centre, adding USD 36.93 Million between 2025 and 2032, while Latin America and Middle East & Africa record the highest regional growth rates. The share of pyraclostrobin intermediates is set to rise from 25.0% in 2025 to 27.8% in 2032, and high-purity grades will continue to gain share as registration specifications tighten.
The Strobilurin Intermediates Market market is projected to grow at a CAGR of 6.7% from 2022 to 2032.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansDefinition
Strobilurin intermediates are the organic chemical compounds that are synthesised and isolated during the multi-step manufacture of strobilurin fungicide active ingredients. Strobilurins are synthetic analogues of the natural antifungal compound strobilurin A, first isolated from the wood-rotting fungus Strobilurus tenacellus. They share a methoxyacrylate, methoxyiminoacetate, methoxycarbamate or related toxophore, which binds the Qo site of the mitochondrial cytochrome bc1 complex and stops fungal respiration.
Typical intermediates covered by this study include:
Azoxystrobin intermediates: benzofuran-2(3H)-one (benzofuranone) and its derivatives, methyl (E)-2-(2-hydroxyphenyl)-3-methoxyacrylate, 4,6-dichloropyrimidine, methyl (E)-2-[2-(6-chloropyrimidin-4-yloxy)phenyl]-3-methoxyacrylate and 2-cyanophenol (salicylonitrile).
Pyraclostrobin intermediates: 1-(4-chlorophenyl)-1H-pyrazol-3-ol, 2-nitrobenzyl halides, and the nitro, hydroxylamine and N-hydroxycarbamate intermediates formed before the final methylation step.
Other strobilurin intermediates: methyl (E)-2-(2-bromomethylphenyl)-2-methoxyiminoacetate and related compounds used for trifloxystrobin and kresoxim-methyl, and pyridine-based building blocks used for picoxystrobin.
Included: intermediates produced for captive use by integrated technical manufacturers and those sold on the merchant market, across both purity grades (98% & Above and Below 98%). Market value is measured at the intermediate stage. Excluded: finished strobilurin technical-grade active ingredients, formulated fungicide products (SC, WG, EC and other formulations), basic commodity chemicals that are not specific to strobilurin synthesis, and intermediates for non-strobilurin fungicides.
Research Objectives
To estimate the size of the global strobilurin intermediates market for 2022–2025 and forecast it to 2032 in USD Million.
To analyse the market by downstream product (azoxystrobin, pyraclostrobin and others) and by purity (98% & Above and Below 98%).
To assess regional and country-level demand across North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
To identify the drivers, restraints, opportunities, trends and challenges that shape demand for strobilurin intermediates, including fungicide resistance and regulatory reviews.
To map the value chain from basic chemical inputs to technical manufacturers, formulators and growers.
To evaluate the regulatory frameworks governing strobilurin active ingredients and chemical manufacturing in key regions.
To profile the competitive environment, including the positioning, capabilities and recent developments of leading producers.
To identify growth pockets for intermediates producers, such as high-purity grades and pyraclostrobin supply chains.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansOverview of the Research Process
The study follows a structured process that combines secondary research, primary research, market size estimation and validation. The process starts with defining the market and its segmentation, followed by collecting information on strobilurin technical production, intermediate synthesis routes, capacity, trade flows and pricing. Market estimates are then built using top-down and bottom-up approaches, cross-checked through data triangulation, and validated with industry participants before forecasts are finalised.
Step 1 – Market definition and scoping: defining strobilurin intermediates, the segmentation framework and the geographic coverage.
Step 2 – Secondary research: collecting data from public and paid sources on fungicide demand, technical capacity, trade and regulation.
Step 3 – Primary research: discussions with supply-side and demand-side participants to validate assumptions, prices and growth expectations.
Step 4 – Market estimation and forecasting: building the base-year model and projecting it to 2032.
Step 5 – Validation: reconciling estimates across segments, regions and countries.
Secondary Research
Secondary research covered sources that are specific to the crop protection and fine chemicals industries:
Industry associations: CropLife International and regional bodies, the Fungicide Resistance Action Committee (FRAC), the China Crop Protection Industry Association (CCPIA), the Pesticides Manufacturers & Formulators Association of India (PMFAI) and the Crop Care Federation of India.
Government and regulatory bodies: the U.S. Environmental Protection Agency (EPA), the European Food Safety Authority (EFSA), the European Commission EU Pesticides Database, the European Chemicals Agency (ECHA), China's Institute for the Control of Agrochemicals, Ministry of Agriculture and Rural Affairs (ICAMA), India's Central Insecticides Board & Registration Committee (CIB&RC), Brazil's Ministry of Agriculture and Livestock (MAPA) and Health Canada's Pest Management Regulatory Agency (PMRA).
Trade and statistical databases: UN Comtrade, national customs data and the USDA National Agricultural Statistics Service (NASS) agricultural chemical use surveys.
Company sources: annual reports, stock-exchange filings, investor presentations, environmental impact assessment disclosures for new plants, and product catalogues of technical and intermediates manufacturers.
Trade journals and technical literature: agrochemical trade publications, patent databases covering azoxystrobin and pyraclostrobin process routes, and peer-reviewed literature on QoI fungicides and resistance.
Paid databases: company financial databases, chemical price trackers and agrochemical market intelligence services.
Primary Research
Primary research was used to validate the secondary findings and to fill gaps in public data. Interviews and discussions were held with participants across the value chain.
Supply side: manufacturers of strobilurin intermediates, integrated technical producers, contract manufacturers, raw material suppliers and process technology providers. Respondents included plant heads, business development managers, production managers and procurement managers.
Demand side: strobilurin technical manufacturers that buy intermediates, formulators, distributors and agronomy experts familiar with fungicide use patterns by crop and region.
The objectives of primary research were to validate capacity and utilisation levels, understand intermediate pricing and purity requirements, confirm the share of captive versus merchant supply, assess regional demand patterns, and test the drivers and restraints used in the forecast.
Market Size Estimation
Top-down approach: the global strobilurin fungicide technical market was used as the starting point. Strobilurin technical volumes were split by active ingredient and converted to intermediate requirements using process stoichiometry and typical yields. Intermediate volumes were then multiplied by average selling prices to arrive at market value, which was allocated to regions and countries based on technical production, consumption and trade data.
Bottom-up approach: capacity, production and pricing information for leading intermediates and technical producers was aggregated by country and region. Country-level demand for intermediates was derived from local technical production and imports, and summed to regional and global totals.
Data triangulation: results from both approaches were compared and reconciled. Where differences arose, the estimates were adjusted using primary research inputs, trade data and company disclosures, so that segment, region and country values are consistent with the global total.
Forecasting Methodology
Forecasts were developed by combining historic trends with an assessment of the factors expected to influence demand over 2026–2032. Factors considered include:
Growth in fungicide-treated crop area and fungicide application intensity, particularly for soybean, cereals, corn, rice, fruits and vegetables.
Share of strobilurins within fungicide programmes, including mixture products with SDHI and triazole fungicides.
Capacity additions, plant utilisation and pricing of strobilurin technicals and intermediates in China and India.
Regulatory reviews and renewals of strobilurin active ingredients in major markets.
The impact of fungicide resistance management practices on application rates.
Macroeconomic factors, including agricultural commodity prices, farm incomes, energy costs and exchange rates.
The forecast model applies segment-specific growth rates by region and country. Results were reviewed with industry participants and adjusted where necessary.
Assumptions and Limitations
Market values are expressed in USD Million at nominal prices. Exchange-rate movements against the U.S. dollar are not modelled separately.
No major disruptive regulatory action, such as the non-renewal of azoxystrobin or pyraclostrobin in a major market, is assumed during the forecast period.
Strobilurin intermediates consumed captively by integrated producers are valued at prevailing merchant market prices.
Price assumptions reflect the normalisation of the 2023–2024 destocking cycle and do not assume a repeat of the 2021–2022 price spike.
Company-level information is based on public disclosures, which vary in detail. Private companies, which are common in this industry, disclose limited data on capacity and sales.
Forecasts are subject to uncertainty from weather-driven disease pressure, agricultural commodity cycles and trade policy changes.
Base Year
2025
Historical Period
2022 – 2024
Forecast Period
2026 – 2032
Primary Interviews
150+
Historical data (2022–2025) and forecast period (2025–2032)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansIntroduction
The global strobilurin intermediates market is moderately fragmented. Production is highly concentrated in China, which accounts for the majority of global capacity for azoxystrobin, pyraclostrobin and trifloxystrobin technicals and their key intermediates, while India is emerging as a second manufacturing base. At the company level, however, the market includes a large number of producers. Industry sources have reported more than 80 pyraclostrobin producers in China, and at least ten significant azoxystrobin producers.
The market has three groups of participants. The first is the originators, Syngenta, BASF and Bayer, which discovered or own the leading strobilurins and continue to lead in brands, mixture products, registrations and technical innovation, while increasingly sourcing generic supply from lower-cost producers. The second is integrated Chinese technical producers, which have built backward integration into intermediates to compete on cost. The third is Indian manufacturers and specialist intermediate producers that are adding capacity under domestic registrations. Competition is mainly based on cost, purity and consistency, environmental compliance, scale, and access to registrations and long-term supply contracts with multinational buyers.
Key Player Positioning
Leaders: Syngenta Group, BASF and Bayer lead the downstream strobilurin market through their original molecules, global distribution, extensive mixture portfolios and regulatory expertise. Syngenta, the originator of azoxystrobin, reported group sales of USD 28.4 billion in FY2025 and is shifting its manufacturing towards new chemistry, with generic supply increasingly sourced from lower-cost options. BASF, the originator of pyraclostrobin, reported FY2025 sales of EUR 59.7 billion, of which its Agricultural Solutions segment contributed EUR 9.59 billion, and it is protecting its franchise through mixtures and lifecycle registrations. Bayer markets trifloxystrobin and fluoxastrobin and reported FY2025 sales of EUR 45.6 billion.
Challengers: CAC Nantong Chemical, Nutrichem, Limin Group, Jiangsu Yangnong Chemical and Hailir are large Chinese technical producers with integrated intermediate capability and export reach. CAC Nantong Chemical is among China's largest azoxystrobin producers and is expanding integrated azoxystrobin and trifloxystrobin capacity. Nutrichem holds patented azoxystrobin process and intermediate routes. Limin Group supplies azoxystrobin through its Hebei Veyong subsidiary and has signed long-term supply agreements with multinationals. Yangnong and Hailir produce pyraclostrobin within broader technical portfolios.
Niche players: Shandong Kangqiao Bio-Technology is a pyraclostrobin specialist with planned capacity of 5,000 tonnes per year. Heranba Industries and Best Agrolife are Indian producers of strobilurin technicals, focusing on picoxystrobin, trifloxystrobin and pyraclostrobin. Other notable participants include Inner Mongolia Lingsheng Crop Science and Jiangxi Lianbai, which are adding azoxystrobin capacity, Zhejiang Zhongshan Chemical in trifloxystrobin, and specialist intermediate producers such as Liaoning Shenglian Biotechnology, which manufactures benzofuranone intermediates.
Threat of New Entrants – Medium
Process technologies for off-patent strobilurins are well documented, and several new Chinese and Indian entrants have announced capacity.
Environmental approvals, process safety requirements and the need to meet buyer specifications raise entry costs and lead times.
Incumbents benefit from scale, integration and established customer relationships.
Bargaining Power of Suppliers – Medium
Most raw materials are commodity or semi-commodity chemicals available from multiple suppliers, mainly in China.
Supply disruptions and price spikes for specific inputs, such as bromine or chlorination reagents, can affect costs in the short term.
Bargaining Power of Buyers – High
Buyers are technical manufacturers and multinational crop-protection companies with significant purchasing power and multiple qualified suppliers.
Intermediates are largely specification-based products, which makes switching between qualified suppliers feasible.
Overcapacity in China strengthens buyer leverage in price negotiations.
Threat of Substitutes – Medium
Alternative fungicide classes, including SDHIs, triazoles, newer modes of action and biological fungicides, compete with strobilurins.
Strobilurins are often used in mixtures with these products rather than being fully replaced, which moderates the threat.
Intensity of Competitive Rivalry – High
A large number of producers, particularly in China, compete on price for azoxystrobin and pyraclostrobin intermediates.
Capacity additions and periodic destocking cycles intensify price competition.
Differentiation is limited to purity, consistency, integration and compliance credentials.
Threat of New Entrants: Medium; Known process routes, offset by environmental approvals and scale requirements.
Bargaining Power of Suppliers: Medium; Commodity inputs with multiple sources; periodic price spikes.
Bargaining Power of Buyers: High; Concentrated buyers, specification-based products, overcapacity.
Threat of Substitutes: Medium; Competing fungicide classes, but strobilurins used in mixtures.
Competitive Rivalry: High; Many producers, price competition, cyclical demand.
Market estimates by geography (2032)
InsightAsia Pacific leads with $99.55M by 2032, while Middle East & Africa is projected to grow fastest at a 7.6% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2022 | 2025 | 2032 | CAGR | SHARE |
|---|---|---|---|---|---|
| North America | $4.11M | $5.37M | $7.09M | 5.6% | 6% |
| Europe | $5.51M | $7.08M | $9.13M | 5.2% | 7% |
| Asia Pacific | $51.13M | $71.62M | $99.55M | 6.9% | 79% |
| Latin America | $3.83M | $5.58M | $7.93M | 7.5% | 6% |
| Middle East & Africa | $1.28M | $1.86M | $2.67M | 7.6% | 2% |
| Total | $65.85M | $91.52M | $126.38M | 6.7% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$126.38M
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Azoxystrobin | $60.39M | 6.0% | 48% |
| Pyraclostrobin | $35.09M | 8.6% | 28% |
| Others | $30.90M | 6.2% | 24% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.

Analytical insights on Strobilurin Intermediates Market covering market dynamics, competitive landscape, and strategic outlook.
The Strobilurin Intermediates Market market is projected to reach $126.38M by 2032, growing at 6.7% CAGR. The Azoxystrobin segment holds the largest share.
Demand for strobilurin intermediates is derived from the production of strobilurin technical-grade active ingredients, which in turn depends on fungicide use by growers. The market is therefore shaped by agricultural factors such as crop area, disease pressure and farm economics, and by industrial factors such as plant capacity, process costs and the regulation of chemical manufacturing. This chapter sets out the factors that promote and inhibit growth, followed by the main drivers, restraints, opportunities, trends and challenges. The impact scores in Table 4.1 are analyst assessments on a scale of 1 to 10, where 10 indicates the strongest impact on the market in the period shown.
Rising Fungicide Use to Protect Crop Yields
Fungal diseases cause substantial yield losses in staple and high-value crops, and growers have steadily increased fungicide applications to protect yields and quality. Strobilurins are among the most widely used fungicide classes because they offer broad-spectrum preventive activity against ascomycetes, basidiomycetes and oomycetes, and they are registered on cereals, soybean, corn, rice, fruits, vegetables and turf. Soybean rust (Phakopsora pachyrhizi) in Brazil and other South American countries requires several fungicide sprays per season, while rice blast and sheath blight drive fungicide use across Asia. Higher-value horticulture in China, India and Latin America also relies on strobilurin-based products for disease control. Each additional tonne of strobilurin technical requires a defined quantity of intermediates, so growth in treated area and spray frequency translates directly into intermediate demand. Climate variability, including warmer and more humid growing seasons in several regions, has increased disease pressure and supports this trend.
Generic Production of Off-Patent Strobilurins
The core patents protecting azoxystrobin and pyraclostrobin have expired, opening the market to generic producers. Chinese manufacturers expanded technical capacity rapidly after patent expiry, and many integrated backwards into key intermediates to control cost and supply. Generic availability has lowered the cost of strobilurin products for growers, widening their use in price-sensitive markets in Asia, Latin America and Africa. Producers continue to add capacity. Recent examples include integrated azoxystrobin projects in Jiangsu and Inner Mongolia and a planned 5,000 tonne-per-year pyraclostrobin plant in Shandong. In India, companies such as Best Agrolife and Heranba have obtained domestic manufacturing registrations for strobilurin technicals, which creates new demand for locally produced or imported intermediates. This expanding generic base is the main volume driver for intermediates through the forecast period.
Growth of Mixture and Combination Products
Resistance-management guidance from FRAC recommends that QoI fungicides be used in mixtures with partners from other modes of action. As a result, the industry has launched a large number of combination products that pair strobilurins with triazoles (such as tebuconazole, difenoconazole and cyproconazole) and SDHIs (such as boscalid, fluxapyroxad and benzovindiflupyr). These mixtures have extended the commercial life of strobilurins and sustained their volumes even as resistance has emerged in some pathogens. Originators and generic companies continue to register new mixtures. For example, BASF introduced Aramax Intrinsic, a pyraclostrobin and triticonazole fungicide for U.S. turf, in 2024, and Indian companies have registered pyraclostrobin and trifloxystrobin combination products for domestic crops. Each new mixture registration adds an additional channel of demand for strobilurin technicals and their intermediates.
Supply Chain Diversification and Backward Integration
Buyers of agrochemical actives have sought to reduce reliance on a single country for critical inputs, following supply disruptions and price spikes in 2021–2022. This China-plus-one approach supports investment in intermediates and technical capacity in India and, to a smaller extent, in other regions. At the same time, Chinese producers are investing in backward integration to secure intermediate supply and lower cost, as illustrated by CAC Nantong Chemical's approved workshops for benzofuranone and sodium salicylonitrile, two azoxystrobin intermediates. Both trends increase the volume of intermediates produced and traded and encourage investment in higher-purity grades that meet the specifications of multinational buyers.
Expanding Fungicide Demand in Latin America
Brazil and Argentina are among the largest markets for soybean and corn fungicides, and demand for pyraclostrobin and azoxystrobin mixtures continues to rise with crop area. Latin America is the second-fastest-growing region in this market, with a CAGR of 7.34% over 2026–2032. Intermediates producers that can supply technical manufacturers serving Brazilian registrations, either directly or through Chinese and Indian partners, are well placed to benefit.
Growth of Indian Manufacturing
India is the fastest-growing country in Asia Pacific, with a CAGR of 7.48%. Indian companies are commissioning multi-product technical plants and obtaining domestic manufacturing registrations for azoxystrobin, pyraclostrobin, trifloxystrobin and picoxystrobin. This creates opportunities for producers of high-purity intermediates, both within India and as suppliers to Indian technical producers that seek alternatives to imported intermediates.
Process Innovation and Green Chemistry
Process routes for azoxystrobin and pyraclostrobin continue to be refined through new catalysts, solvent recovery and continuous-flow technologies that improve yield, reduce effluent and raise purity. Several companies have patented improved processes for key steps, such as the coupling of methyl (E)-2-[2-(6-chloropyrimidin-4-yloxy)phenyl]-3-methoxyacrylate with 2-cyanophenol. Producers that lower cost and environmental impact can gain share in a price-competitive market and qualify as preferred suppliers for multinational customers.
Development of QoI Fungicide Resistance
Strobilurins act on a single target site, which makes them prone to resistance. The G143A mutation in the cytochrome b gene confers high levels of resistance and has been reported in many pathogens, including Zymoseptoria tritici in European wheat, powdery mildews and several Alternaria and Cercospora species. Resistance has reduced the use of strobilurins as stand-alone products and limited the number of applications per season under resistance-management guidelines. This caps volume growth in mature markets, especially in Europe, and shifts demand towards mixtures in which the strobilurin share of active ingredient per hectare is lower.
Price Pressure and Overcapacity
Capacity for strobilurin technicals and intermediates in China has grown faster than demand. Industry analyses have reported more than 80 pyraclostrobin producers in China. During the 2023–2024 destocking cycle, distributors and formulators reduced inventories and fungicide technical prices fell sharply. Lower prices reduce the value of the intermediates market even when volumes rise, compress producer margins and delay new investments.
Stricter Environmental and Safety Regulation
The synthesis of strobilurin intermediates involves chlorination, nitration, cyanation and methylation steps that generate hazardous waste and require careful process safety management. Environmental inspections and chemical park rectification programmes in China, including those that followed the 2019 Xiangshui explosion in Jiangsu, have raised compliance costs and led to the closure or relocation of smaller plants. Tighter regulation in India and Europe has a similar effect on cost and lead times for new capacity.
Challenge: Regulatory Renewals of Strobilurin Actives
Strobilurin active ingredients are subject to periodic review in major markets. In the European Union, pyraclostrobin's approval was renewed in 2026 for a further 15 years with conditions, while the renewal assessments for azoxystrobin and kresoxim-methyl remain in progress and their approval periods have been extended. Any restriction arising from these reviews would directly affect demand for the related intermediates.
Challenge: Cyclical Pricing and Inventory Swings
Prices for fungicide technicals and intermediates are cyclical and sensitive to inventory levels in the distribution channel. After the sharp rise in 2021–2022, prices fell during the 2023–2024 destocking period and have since stabilised near cost levels for several products. Such swings complicate capacity planning and can erode margins for producers that lack scale or integration.
Trend: Backward Integration by Technical Producers
Leading Chinese technical producers are integrating into their key intermediates to secure supply, control impurity profiles and reduce cost. This reduces the size of the merchant market for some intermediates but raises overall production and investment in intermediate capacity.
Trend: Shift Towards High-Purity Grades
Registration authorities set minimum purity requirements and limits for relevant impurities in technical-grade active ingredients. To meet these, technical producers increasingly specify intermediates of 98% purity and above. The 98% & Above segment grows at 6.97%, compared with 4.96% for the Below 98% segment.
The strobilurin intermediates value chain runs from basic and specialty chemical inputs through intermediate synthesis and technical manufacture to formulation and end use on crops.
Raw Materials and Inputs
Key inputs include aromatic building blocks such as phenol derivatives, o-hydroxyphenylacetic acid, salicylamide, o-nitrotoluene and p-chloroaniline; heterocyclic precursors such as 4,6-dihydroxypyrimidine; and reagents including methanol, methyl formate, trimethyl orthoformate, dimethyl sulfate, methyl chloroformate, phosphorus oxychloride, bromine and solvents. Many of these are produced in China, which gives Chinese intermediates producers a cost advantage. Energy, catalysts and waste treatment are significant cost items.
Intermediate Manufacturing
Intermediates are produced by specialty chemical companies and by integrated technical producers. For azoxystrobin, benzofuranone is converted into a methoxyacrylate intermediate, which is coupled with 4,6-dichloropyrimidine and then with 2-cyanophenol. For pyraclostrobin, 1-(4-chlorophenyl)-1H-pyrazol-3-ol is coupled with a 2-nitrobenzyl halide, reduced, carbamoylated and methylated. Quality control focuses on purity, isomer content and relevant impurities.
Technical Manufacture and Formulation
Technical producers convert intermediates into strobilurin technical-grade active ingredients (TC), which are sold to formulators or used captively to make suspension concentrates, water-dispersible granules, emulsifiable concentrates and mixtures with other fungicides.
Distribution and Channels
Intermediates are sold directly under supply contracts between producers and technical manufacturers, often on a long-term basis with defined specifications. Merchant traders play a role in export markets. Finished fungicides reach growers through national distributors, retailers and cooperatives.
End Users
The direct customers for intermediates are strobilurin technical manufacturers. The final end users are growers of soybean, cereals, corn, rice, fruits, vegetables, plantation crops and turf, whose fungicide purchases determine demand throughout the chain.
North America
United States: pesticide active ingredients and products are registered by the EPA under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). Residue tolerances are set under the Federal Food, Drug, and Cosmetic Act (FFDCA), as amended by the Food Quality Protection Act of 1996. Registered pesticides undergo periodic registration review. Chemical intermediates that are not themselves pesticides fall under the Toxic Substances Control Act (TSCA).
Canada: pest control products are regulated by Health Canada's Pest Management Regulatory Agency (PMRA) under the Pest Control Products Act.
Mexico: pesticide registration involves the Federal Commission for the Protection against Sanitary Risk (COFEPRIS).
Europe
Regulation (EC) No 1107/2009 governs the approval of active substances and the authorisation of plant protection products in the EU. Pyraclostrobin's approval was renewed in 2026 for 15 years with conditions, while azoxystrobin and kresoxim-methyl approvals have been extended pending completion of their renewal assessments.
Regulation (EC) No 396/2005 sets maximum residue levels (MRLs) for pesticides in food and feed.
REACH, Regulation (EC) No 1907/2006, applies to chemical intermediates manufactured in or imported into the EU, with specific provisions for on-site and transported isolated intermediates. CLP, Regulation (EC) No 1272/2008, governs classification and labelling.
Directive 2009/128/EC on the sustainable use of pesticides promotes integrated pest management. In Great Britain, the Health and Safety Executive administers pesticide approvals under its domestic regime.
Asia Pacific
China: pesticide production, registration and use are governed by the Regulations on Pesticide Administration (revised in 2017), with registration managed by ICAMA under the Ministry of Agriculture and Rural Affairs. New intermediates and technical plants require environmental impact assessment approval and must be located in approved chemical parks.
India: pesticides are regulated under the Insecticides Act, 1968 and the Insecticides Rules, 1971, with registration by CIB&RC. Indigenous manufacture of technicals requires registration under Section 9(3) of the Act.
Japan: agricultural chemicals are regulated under the Agricultural Chemicals Control Act, with residue standards set under the Food Sanitation Act.
Latin America
Brazil: Law No. 14,785 of 2023 replaced the earlier pesticide law and redefined the registration process, with MAPA as the coordinating authority alongside health and environmental agencies.
Argentina: plant protection products are registered by the National Agri-Food Health and Quality Service (SENASA).
Middle East & Africa
South Africa: agricultural remedies are registered under the Fertilizers, Farm Feeds, Agricultural Remedies and Stock Remedies Act, 1947 (Act No. 36 of 1947).
Gulf countries: pesticide registration is handled by national agriculture and environment ministries, with growing alignment on product standards across the Gulf Cooperation Council.
Jun 2022: Hailir Pesticides and Chemicals; Expansion; Phase I of the Qingdao Hengning technicals and intermediates project (RMB 2 billion, 40,000 t/yr) entered full production.
Mar 2023: Best Agrolife; Investment; Board approved capex of INR 200 crore, including INR 150 crore for brownfield expansion of its technical manufacturing unit.
Jun 2023: Best Agrolife; Registration; Received CIB&RC registrations for additional technicals and pyraclostrobin-based combination products, building on its existing pyraclostrobin technical approval.
Oct 2023: Best Agrolife; Acquisition; Acquired a 99% stake in formulation manufacturer Kashmir Chemicals.
Dec 2023: CAC Nantong Chemical; Expansion; Received environmental approval for new workshops, including 8,254 t/yr benzofuranone acetic anhydride solution and 2,336 t/yr sodium salicylonitrile, both azoxystrobin intermediates.
May 2024: BASF SE; Launch; Introduced Aramax Intrinsic, a pyraclostrobin and triticonazole fungicide for U.S. turf.
May 2024: Nutrichem Company; Expansion; Reported process optimisation for its 4,000 t/yr azoxystrobin project, with a new catalyst expected to be introduced.
Aug 2024: Hailir Pesticides and Chemicals; Expansion; Part of Phase II (technicals) of the Qingdao Hengning project started production.
Apr 2025: CAC Nantong Chemical; Investment; Listed on the Shenzhen ChiNext board; part of the proceeds funds a project for azoxystrobin, trifloxystrobin and their intermediates.
Apr 2025: Heranba Industries; Expansion; Subsidiary Heranba Organics began commercial production at its Saykha unit, with Phase I capacity of about 6,000 MTPA.
Jun 2025: Heranba Industries; Expansion; Commissioned Phase II of its Sarigam plant, adding up to 9,000 MTPA of fungicide and insecticide capacity.
Sep 2025: CAC Nantong Chemical; Investment; Raised the budget of its azoxystrobin technical project from RMB 229 million to RMB 397 million.
Nov 2025: BASF SE; Corporate; Announced plans to list its Agricultural Solutions division, which holds its strobilurin fungicide business, on the Frankfurt Stock Exchange, targeted for 2027.
Jan 2026: Shandong Kangqiao Bio-Technology; Expansion; Announced a 7,000 t/yr technicals plant at Boxing Chemical Industrial Park, including 5,000 t/yr of pyraclostrobin.
Feb 2026: Limin Group; Partnership; Signed a long-term agrochemical supply agreement with Bayer S.A. worth up to about RMB 1.6 billion over six years.
Oct 2026: Syngenta Group; Restructuring; Began consultation on the proposed closure of its Grangemouth active ingredient manufacturing site in the U.K., the site historically used for azoxystrobin production.
Political
Trade tensions and tariffs between major economies affect flows of intermediates and technicals from China.
Government support for domestic chemical manufacturing in India encourages local intermediate production.
Food security policies in the Middle East and Asia support investment in crop protection.
Economic
Agricultural commodity prices and farm incomes influence growers' spending on fungicides.
Overcapacity and destocking cycles cause sharp swings in intermediate and technical prices.
Energy and raw material costs significantly affect production economics.
Social
Rising food demand and changing diets increase the need for higher crop yields and quality.
Public concern about pesticide residues encourages stricter MRLs and integrated pest management.
Technological
Improved catalysts, continuous-flow processes and solvent recovery raise yields and purity.
Development of new mixture formulations extends the commercial life of strobilurins.
Digital agriculture and disease forecasting improve the timing and targeting of fungicide sprays.
Environmental
Strict effluent and emission standards for chemical plants raise compliance costs.
Climate change alters disease patterns and can increase fungicide demand in some regions.
Concerns about aquatic toxicity of strobilurins influence label conditions and buffer zones.
Legal
Periodic re-registration and renewal of active ingredients in the EU, U.S. and other markets.
Process patents held by originators and generic producers shape the routes available to new entrants.
Chemical safety laws, including REACH and TSCA, govern the manufacture and import of intermediates.
Profiles of 106 companies operating in the Strobilurin Intermediates Market market, including revenue, employee count, and market positioning where available.
Showing 106 of 106 companies
BASF is the world's largest chemical company by sales, built on the Verbund principle of physically and energetically integrated production sites that turn a handful of feedstocks into thousands of products. Since September 2024 it has run under the "Winning Ways" strategy, which splits the portfolio into four core segments (Chemicals, Materials, Industrial Solutions, Nutrition & Care) that stay integrated, and standalone businesses (Agricultural Solutions, Battery Materials, Environmental Catalyst and Metal Solutions, and the now-divested Coatings) that are being monetized or prepared for capital-market options. In 2025 it generated €59.7 billion in sales and €6.6 billion in EBITDA before special items, a cyclical trough. In 2026 it closed the €7.7 billion Coatings transaction, started up its €-multi-billion Zhanjiang Verbund site, raised earnings guidance, and approached Evonik about a takeover. The investment debate is whether structural cost cuts and portfolio proceeds can restore returns above the cost of capital. --- **The company's own description.** BASF describes its purpose with the line "we create chemistry for a sustainable future" (BASF news release boilerplate, 2026) and states its ambition to be the preferred chemical company for enabling customers' green transformation. It reports around 108,000 employees, customers in nearly every sector and almost every country, and sales of around €60 billion in 2025. The portfolio is described as four core segments plus standalone businesses bundled in Surface Technologies and Agricultural Solutions. **Independent characterization.** BASF is best understood as three businesses under one roof: 1. **An integrated commodity and intermediates engine** (Chemicals, the Monomers half of Materials). This is a steam-cracker-to-derivatives chain selling ethylene and propylene derivatives, isocyanates, polyamide precursors and intermediates on spread economics. Earnings are driven by feedstock and energy costs, operating rates and regional supply-demand. It is the most capital-intensive part of the group and the main source of the 2023–2025 earnings decline: Chemicals EBITDA before special items fell from €1,342 million in 2024 to €853 million in 2025 (Factsheet FY2025). 2. **Formulated and performance products** (Performance Materials, Industrial Solutions, Nutrition & Care). These sell on specification and performance to automotive, construction, packaging, consumer goods, pharma and nutrition customers. Margins are steadier but have come under pressure from Asian competition and, in Care Chemicals, from consumer trading-down to private-label products (Factsheet FY2025 commentary). 3. **Standalone franchises** with different industry logic: Agricultural Solutions (crop protection, seeds and traits, digital farming), ECMS (emissions catalysts plus precious-metal trading and recycling) and Battery Materials. Agricultural Solutions is the group's highest-margin segment at 21.7% EBITDA margin before special items in FY2025 and the largest single earnings contributor at €2,081 million. **Revenue model.** Revenue is almost entirely product sales under supply contracts and spot transactions. There is no subscription model of consequence; digital farming (xarvio) and licensing of process technology and catalysts are small. Seeds and traits include royalty and licensing income within Agricultural Solutions, not separately disclosed. Precious-metal trading inflates ECMS sales (€7,978 million in FY2025) with pass-through metal value, which is why BASF quotes group margins both including and excluding metals (12.3% excluding metals in FY2025 per the CFO on the February 27, 2026 call, versus 11.0% reported). **Value chain position.** Upstream to midstream in petrochemicals with captive crackers at Ludwigshafen, Antwerp, Port Arthur (joint venture with TotalEnergies), Nanjing (joint venture with Sinopec) and Zhanjiang; midstream to downstream in engineering plastics, polyurethane systems, dispersions, additives, surfactants and vitamins; branded and channel-driven in agriculture. BASF exited upstream oil and gas operations when Wintershall Dea's E&P business was transferred to Harbour Energy in September 2024. **Customers and end-markets.** BASF serves industrial customers in chemicals and plastics, transportation, construction, consumer goods, agriculture, electronics, energy and resources, and health and nutrition. Intersegment transfers are large (Chemicals transferred €3,432 million internally in FY2025 on €10,055 million of third-party sales), which shows how much of the upstream output feeds BASF's own downstream chains.
Bayer is a German life-science group with three businesses: Crop Science, Pharmaceuticals and Consumer Health. It is the world's largest combined seed, trait and crop-protection supplier, a mid-sized prescription-drug maker, and a top-five self-care company. Fiscal 2025 sales were EUR 45.6 billion. The 2018 purchase of Monsanto brought leading corn and soybean genetics but also glyphosate and PCB litigation, which has consumed well over EUR 10 billion in settlements and produced net losses in 2023, 2024 and 2025. Under CEO Bill Anderson the company has cut management layers, held the dividend at the legal minimum, and concentrated on four priorities: rebuilding the pharma pipeline, containing litigation, reducing debt and improving crop profitability. In 2026 a 7–2 U.S. Supreme Court ruling on federal pre-emption and a proposed USD 7.25 billion class settlement moved the litigation closer to resolution, though the settlement still awaits final court approval. --- **Company's own description.** Bayer describes itself as a global enterprise with core competencies in the life-science fields of health care and nutrition, operating under the mission "Health for all, Hunger for none" (Annual Report 2025; press boilerplate 2026). Bayer AG is a holding company; operations sit in subsidiaries worldwide. In fiscal 2025 the Group had about 88,000 employees, sales of EUR 45.6 billion and R&D expenses of EUR 5.8 billion. **Independent characterisation.** Bayer is best understood as three distinct businesses sharing a balance sheet, a brand and a legal liability. Crop Science (47 percent of FY2025 sales) is an input supplier to farmers. It earns money from proprietary seed and biotech traits, from chemical and biological crop protection, and to a small extent from digital farming subscriptions. Seed and trait revenue carries royalty-like economics: Bayer licenses traits to other seed companies, and two licensing settlements with Corteva lifted results in Q4 2025 and Q1 2026. The business is strongly seasonal, with Northern Hemisphere sales concentrated in the first half and Latin American sales in the second. Pharmaceuticals (39 percent of sales) discovers, develops and sells prescription medicines, concentrated in cardiovascular and renal disease, oncology, women's health and ophthalmology, plus a radiology unit selling contrast agents and injector hardware. Revenue is almost entirely product sales, with some licence income (for example U.S. Xarelto royalties from Johnson & Johnson, and Eylea outside the United States under a collaboration with Regeneron). The division is in the middle of a patent transition: Xarelto and Eylea are declining while Nubeqa and Kerendia are growing quickly. Consumer Health (13 percent of sales) sells non-prescription brands through pharmacies, mass retail and e-commerce. It is a branded consumer-goods model with stable margins and low capital intensity. **Revenue model mix.** Bayer does not disclose a product/service/licensing split. On the evidence of the Annual Report 2025, the large majority of revenue is product sales; licensing income is embedded in Crop Science seed and trait lines and in Pharmaceuticals; subscription revenue (Climate FieldView, radiology software) is immaterial at Group level. An exact percentage split is not publicly disclosed. **Value-chain position.** Bayer is a research-based originator and manufacturer. It owns discovery, development, active-ingredient and finished-product manufacturing, and commercial organisations, and sells through distributors, retailers, wholesalers, hospitals and pharmacies rather than directly to end users in most markets. **Customers and end markets.** Farmers, agricultural retailers and distributors, and seed licensees (Crop Science); wholesalers, hospitals, physicians, pharmacy chains, governments and payers (Pharmaceuticals); pharmacies, supermarkets, drugstores and online retailers (Consumer Health).
3 interactive charts drawn from the Strobilurin Intermediates Market dataset — market size, regional splits and each segment breakdown. Open one to read its full data table and download it.
Global Strobilurin Intermediates Market By Purity
Global Strobilurin Intermediates Market By Downstream Product
Global Strobilurin Intermediates Market By Region
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Million)